Checkpoint Inhibitor-Associated Myasthenia–Myositis Overlap With Neuromuscular Respiratory Failure After Dual PD-L1 Plus CTLA-4 Checkpoint Blockade for Hepatocellular Carcinoma. The gene discussed is CTLA4; the disease is myositis disease.